Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Painkillers show Alzheimer’s promise

08.11.2001



Ibuprofen could keep more than headaches at bay.
© SPL



More evidence is emerging that over-the-counter painkillers such as ibuprofen could form the basis of future treatments for Alzheimer’s disease. A new study suggests that some non-steroidal anti-inflammatory drugs (NSAIDs) block a process thought to cause the degenerative brain disease.

... mehr zu:
»Alzheimer »Cox »NSAID


In mice and in cultured human cells, certain NSAIDs prevent a harmful variety of a protein called amyloid from forming - instead the cells produce another amyloid. Many believe that Alzheimer’s results when clumps - called plaques - of the harmful amyloid accumulate in the brain.

Better still, the NSAIDs do not seem to effect other brain proteins. Existing Alzheimer’s drugs interfere with all amyloid proteins and other molecules in the brain, causing undesirable side-effects.

"This is the first known set of compounds that inhibit the pathogenic [amyloid]," says Edward Koo, a neuroscientist at the University of California, San Diego, who led the study1.

Although promising, experimental success in cell cultures and mice doesn’t always translate to humans, Koo warns. "This doesn’t mean it’s safe to take these drugs to treat Alzheimer’s," he says. A human would have to consume the equivalent of 16 ibuprofen tablets a day before any effect was seen - far more than the recommended safe dose.

But by looking for compounds that are similar to NSAIDs, Koo hopes to produce a new Alzheimer’s drug with anti-plaque properties but none of the toxic side-effects of either NSAIDs or current Alzheimer’s drugs.

It may be a bit more difficult than that, warns Michael Garavito, a molecular biologist at Michigan State University in East Lansing. "This tantalizing research makes it worthwhile exploring this pathway further," he says, but he doubts that researchers will easily uncover the NSAID connection until Alzheimer’s itself is better understood. "It’s still up in the air as to what is the root cause of Alzheimer’s," he says.

Lack of inflammation

There has long been tantalizing evidence that NSAIDs might alleviate Alzheimer’s disease. Occasionally, Alzheimer’s symptoms are reduced in elderly patients who take NSAIDs to ease pain and inflammatory diseases such as arthritis.

"There’s a major controversy as to what is actually happening," says Garavito. Many NSAIDs, such as aspirin, have no effect on Alzheimer’s symptoms. Others, such as ibuprofen, show some effect but only at high, potentially toxic doses.

The plaque-scotching signs seen by Koo’s team do not seem to be due to the anti-inflammatory properties of NSAIDs. These medicines inhibit inflammation by inducing cooxygenase (COX) enzymes, but the NSAIDs still had their anti-plaque effect in mutant cells that lack COX, the team found.

References

  1. Weggen, S. et al. A subset of NSAIDs lower amyloidogenic Aß42 independently of cyclooxygenase activity. Nature, 414, 212 - 216, (2001).


TOM CLARKE | © Nature News Service
Weitere Informationen:
http://www.nature.com/nsu/011108/011108-10.html

Weitere Berichte zu: Alzheimer Cox NSAID

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Lymphdrüsenkrebs programmiert Immunzellen zur Förderung des eigenen Wachstums um
22.02.2018 | Wilhelm Sander-Stiftung

nachricht Forscher entdecken neuen Signalweg zur Herzmuskelverdickung
22.02.2018 | Ruhr-Universität Bochum

Alle Nachrichten aus der Kategorie: Medizin Gesundheit >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Vorstoß ins Innere der Atome

Mit Hilfe einer neuen Lasertechnologie haben es Physiker vom Labor für Attosekundenphysik der LMU und des MPQ geschafft, Attosekunden-Lichtblitze mit hoher Intensität und Photonenenergie zu produzieren. Damit konnten sie erstmals die Interaktion mehrere Photonen in einem Attosekundenpuls mit Elektronen aus einer inneren atomaren Schale beobachten konnten.

Wer die ultraschnelle Bewegung von Elektronen in inneren atomaren Schalen beobachten möchte, der benötigt ultrakurze und intensive Lichtblitze bei genügend...

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

Eine Gruppe von Forschern um Andrea Cavalleri am Max-Planck-Institut für Struktur und Dynamik der Materie (MPSD) in Hamburg hat eine Methode demonstriert, die es erlaubt die interatomaren Kräfte eines Festkörpers detailliert auszumessen. Ihr Artikel Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, nun online in Nature veröffentlich, erläutert, wie Terahertz-Laserpulse die Atome eines Festkörpers zu extrem hohen Auslenkungen treiben können.

Die zeitaufgelöste Messung der sehr unkonventionellen atomaren Bewegungen, die einer Anregung mit extrem starken Lichtpulsen folgen, ermöglichte es der...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Verlässliche Quantencomputer entwickeln

Internationalem Forschungsteam gelingt wichtiger Schritt auf dem Weg zur Lösung von Zertifizierungsproblemen

Quantencomputer sollen künftig algorithmische Probleme lösen, die selbst die größten klassischen Superrechner überfordern. Doch wie lässt sich prüfen, dass der...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

Von festen Körpern und Philosophen

23.02.2018 | Veranstaltungen

Spannungsfeld Elektromobilität

23.02.2018 | Veranstaltungen

DFG unterstützt Kongresse und Tagungen - April 2018

21.02.2018 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

Vorstoß ins Innere der Atome

23.02.2018 | Physik Astronomie

Wirt oder Gast? Proteomik gibt neue Aufschlüsse über Reaktion von Rifforganismen auf Umweltstress

23.02.2018 | Biowissenschaften Chemie

Wie Zellen unterschiedlich auf Stress reagieren

23.02.2018 | Biowissenschaften Chemie

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics